ANTIGEN BINDING PROTEINS

Antigen binding proteins that bind -amyloid peptide, in particular human -amyloid peptide; methods of treating diseases or disorders characterized by elevated -amyloid levels or -amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve charac...

Full description

Saved in:
Bibliographic Details
Main Authors FORD SUSANNAH KAREN, WATTAM TREVOR ANTHONY KENNETH, ELLIS JONATHAN HENRY, GERMASCHEWSKI VOLKER, SODEN PETER ERNEST, LEWIS ALAN PETER, ALARD PHILIPPE MARC LOUIS, THOMAS PAMELA JOAN, CATCHPOLE IAN RICHARD, GOUGH GERALD WAYNE
Format Patent
LanguageEnglish
Korean
Published 02.09.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Antigen binding proteins that bind -amyloid peptide, in particular human -amyloid peptide; methods of treating diseases or disorders characterized by elevated -amyloid levels or -amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterized by elevated -amyloid levels or -amyloid deposits, including age related macular degeneration and glaucoma type diseases and -amyloid dependent cataract formation, with the antigen binding proteins; pharmaceutical compositions comprising the antigen binding proteins; and methods of manufacture.
Bibliography:Application Number: KR20157022610